Journal of Vascular Surgery
Volume 48, Issue 6, Supplement , Pages 46S-52S , December 2008

The future of vascular surgery: An Australasian perspective

Presented in part at The World Federation of Vascular Societies Meeting, San Diego, Calif, Jun 4, 2008.

  • Philip J. Walker, FRACS(Vasc)

      Affiliations

    • Corresponding Author InformationCorrespondence: Philip J. Walker, FRACS (Vasc), University of Queensland, Department of Surgery, Block 6, Level 7, Room F29, Royal Brisbane and Women's Hospital, Herston QLD 4029 Australia

Received 14 July 2008 ,Accepted 8 August 2008.

References 

  1. Connell J. The history of cardiovascular surgery in Australia. J Cardiovasc Surg (Torino). 1990;31:133–141
  2. King R. The society and the chapter, a short history. Cardiovasc Surg. 1998;6:441–445
  3. Gurry JF. Fifty years of vascular surgery in Australia and New Zealand. ANZ J Surg. 2006;76:655–660
  4. Harris JP. Early development of the vascular laboratory in Australia. ANZ J Surg. 2003;73:540–543
  5. Cronenwett JL, Liapis CD. Vascular surgery training and certification: an international perspective. J Vasc Surg. 2007;46:621–629
  6. Conjoint Committee for the Recognition of Training in Peripheral Endovascular Therapy. http://www.surgeons.org/Content/NavigationMenu/EducationandTraining/PET/default.htmlAccessed: Sep 12, 2008
  7. New Zealand Vascular Society Constitution. http://vsnz.org/constitution.htmAccessed: Sep 12, 2008
  8. Medical Services Advisory Committee. http://www.msac.gov.au/Accessed: Sep 12, 2008
  9. TGA regulatory framework for medical devices. http://www.tga.gov.au/docs/html/tganews/news49/dev.htm2007;Accessed: Sep 12, 2008
  10. Health Insurance Amendment (Diagnostic Imaging Accreditation) Bill 2007. http://www.austlii.edu.au/legis/cth/bill/hiaiab2007507/2008;Accessed: Sep 12, 2008
  11. Costello P. In: Commonwealth of Austalia Department of Treasury. Treasury, editor. Intergenerational report 2007. 2007. http://www.treasury.gov.au/igr. Accessed: Sep 12, 2008.
  12. Australian Institute of Health and Welfare (2008). Australia's health 2008. The eleventh biennial health report of the Australian Institute of Health and Welfare. (AIHW Catalogue no. AUS 99.).
  13. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003;178:427–432
  14. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. Journal of the American Society of Nephrology. 2003;14:S131–S138
  15. Colagiuri S, Borch-Johnsen K, Glümer C, Vistisen D. There really is an epidemic of type 2 diabetes. Diabetologia. 2005;48:1459–1463
  16. Catanzariti L. Incidence of type 1 diabetes in Australia 2000-2006. FK Waters A Australian Institute of Health and Welfare; 2008;Canberra Cat. no. CVD 42
  17. McDonald SP, Russ GR, Kerr PG, Collins JF, Australia and New Zealand Dialysis and Transplant Registry. Australia and New Zealand Dialysis and Transplant Registry; Adelaide, SA, Australia. stephenm@anzdata.org.au.
  18. Eidt JF. Analysis of the current applicant pool to vascular surgery: who are they and where do they come from?. Semin Vasc Surg. 2006;19:172–179
  19. AMA. AMA Safe Hours Campaign. http://www.ama.com.au/web.nsf/doc/SHED-5G3C2R2004;Accessed: Sep 12, 2008
  20. Anderson Adam DJ, Berce M, Hartley DE. Repair of thoracoabdominal aortic aneurysms with fenestrated and branched endovascular stent grafts. J Vasc Surg. 2005;42:600–607
  21. Sandroussi C, Waltham M, Hughes CF, May J, Harris JP, Stephen MS, et al. Endovascular grafting of the thoracic aorta, an evolving therapy: ten-year experience in a single centre. ANZ J Surg. 2007;77:974–980
  22. Mohan IV, Hitos K, White GH, Harris JP, Stephen MS, May J, et al. Improved outcomes with endovascular stent grafts for thoracic aorta transections. Eur J Vasc Endovasc Surg. 2008;36:152–157
  23. Goodman M, Lawrence-Brown MM, Hartley D, Allen YB, Semmens JB. Treatment of infrarenal abdominal aortic aneurysms with oversized (36-mm) Zenith endografts. J Endovasc Ther. 2007;14:23–29
  24. Serracino-Inglott F, Bray A, Myers P. Endovascular abdominal aortic aneurysm repair in patients with common iliac artery aneurysms–initial experience with the Zenith bifurcated iliac side branch device. J Vasc Surg. 2007;46:211–217
  25. STABLE Aortic Dissection Trial. http://www.cookmedical.com2008;Accessed: Sep 12, 2008
  26. Jones GT, Thompson AR, van Bockxmeer FM, Hafez H, Cooper JA, Golledge J, et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol. 2008;28:764–770
  27. Golledge J, Eagle K. Acute aortic dissection. Lancet. 2008;372:55–66
  28. Golledge J, Powell J. Medical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2007;34:267–273
  29. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452:638–642
  30. Golledge J, Karan M, Moran CS, Muller J, Clancy P, Dear AE, et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J. 2008;29:665–672
  31. Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adipokines, and abdominal aortic aneurysm: Health in Men Study. Circulation. 2007;116:2275–2279
  32. Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, et al. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2007;27:655–660
  33. Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26:2605–2613
  34. Nataatmadja M, West J, West M, Millar C, Summers K, Walker P. Vascular smooth muscle cell and skin fibroblast properties in aortic aneurysm associated with bicuspid aortic valve or Marfan syndrome: identification of localised versus systemic abnormalities. Cardiovas Pathol. 2004;13(3 suppl 1):19
  35. Nataatmadja M, West M, West J, Summers K, Walker P, Nagata M, et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation. 2003;108:II329–II334
  36. Lindholt JS, Norman P. Screening for abdominal aortic aneurysm reduces overall mortality in men (a meta-analysis of the mid- and long-term effects of screening for abdominal aortic aneurysms). Eur J Vasc Endovasc Surg. 2008;36:167–171
  37. Smallwood L, Allcock R, van Bockxmeer F, Warrington N, Palmer LJ, Iacopetta B, et al. Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2008;35:31–36
  38. Barnes M, Boult M, Maddern G, Fitridge R. A model to predict outcomes for endovascular aneurysm repair using preoperative variables. Eur J Vasc Endovasc Surg. 2008;35:571–579
  39. CSIRO&ASERNIP-S, A model workbook which predicts success rates of endovascular aneurysm repair (EVAR) for patients, based on results derived from a longitudinal Australian audit. http://www.surgeons.org/Content/NavigationMenu/Research/ASERNIPS/ASERNIPSAudits/Audits.htm2006;Accessed: Sep 12, 2008
  40. Ahimastos AA, Lawler A, Reid CM, Blombery PA, Kingwell BA. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med. 2006;144:660–664
  41. Askew CD, Green S, Walker PJ, Kerr GK, Green AA, Williams AD, et al. Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease. J Vasc Surg. 2005;41:802–807
  42. Wood RE, Sanderson BE, Askew CD, Walker PJ, Green S, Stewart IB. Effect of training on the response of plasma vascular endothelial growth factor to exercise in patients with peripheral arterial disease. Clin Sci. 2006;111:401–409
  43. Sanderson B, Askew C, Stewart I, Walker P, Gibbs H, Green S. Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J Vasc Surg. 2006;44:119–127
  44. Narayan K, Denton M, Das R, Bernshaw D, Rolfo A, van Dyk S, et al. A phase II study of external-beam radiotherapy and endovascular brachytherapy with PTA and stenting for femoropopliteal artery restenosis. Int J Radiat Oncol Biol Phys. 2006;66:238–243
  45. Sanofi-Aventis. The Tamaris Study. http://www.tamaris-study.org/2008;Accessed: Sep 12, 2008
  46. Daly CD, Campbell GR, Walker PJ, Campbell JH. In vivo engineering of blood vessels. Front Biosci. 2004;9:1915–1924
  47. Campbell GR, Campbell JH. Development of tissue engineered vascular grafts. Curr Pharm Biotechnol. 2007;8:43–50
  48. Campbell GR, Turnbull G, Xiang L, Haines M, Armstrong S, Rolfe BE, et al. The peritoneal cavity as a bioreactor for tissue engineering visceral organs: bladder, uterus and vas deferens. J Tissue Eng Regen Med. 2008;2:50–60
  49. Lane R. Hypertensive Extracorporeal Limb Perfusion– the HELP study. http://hyperperfusion.com/2007;Accessed: Sep 12, 2008

 STATEMENT OF CONFLICT OF INTEREST: Philip J. Walker reports the following conflicts of interest with the sponsor of this supplement article or products discussed in this article. P. J. W. is a consultant for Cook Australia and Pharmalink and has received research funding from Cook Australia, Medtronic Australia, W. L. Gore and Associates, and Sanofi-Aventis.

PII: S0741-5214(08)01385-2

doi: 10.1016/j.jvs.2008.08.034

Journal of Vascular Surgery
Volume 48, Issue 6, Supplement , Pages 46S-52S , December 2008

Article Tools